1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 2-2
&NA;,
Preview
|
PDF (843KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
2. |
Osteoporosis becoming a disease of the past? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 3-4
Sean Henahan,
Preview
|
PDF (1536KB)
|
|
摘要:
New evidence is accumulating to suggest that bisphosphonate drugs not only build bone, but also significantly reduce fracture risk in patients receiving long-term corticosteroid therapy. These findings may spell the beginning of the end for osteoporosis, delegates were told at the 1998 Annual Meeting of the American College of Rheumatology [San Diego, US; November 1998].
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
3. |
Palivizumab and RSVIGuse in prevention of RSV infection |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 4-4
&NA;,
Preview
|
PDF (762KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 5-5
&NA;,
Preview
|
PDF (755KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
5. |
Risperidone costly, but cost saving overall |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 6-6
&NA;,
Preview
|
PDF (728KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 7-7
&NA;,
Preview
|
PDF (870KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 8-8
&NA;,
Preview
|
PDF (776KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
8. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 9-9
&NA;,
Preview
|
PDF (802KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
9. |
Miltefosine promising in visceral leishmaniasis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 10-10
&NA;,
Preview
|
PDF (730KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
10. |
Kava each day keeps the blues away |
|
Inpharma Weekly,
Volume &NA;,
Issue 1167,
1998,
Page 11-12
Kate Palmer,
Preview
|
PDF (1577KB)
|
|
摘要:
For the past 30 years, benzodiazepines have been the mainstay of treatment for anxiety and other stress-related symptoms. Although effective, these drugs are associated with a number of adverse effects which limit their use, including their ability to induce tolerance and dependence. The search for alternative anxiolytics has taken researchers along a number of paths, including the assessment of several ‘natural’ products that are anecdotally renown for their anxiolytic effects. The effects of one such traditional medicine, kava (a herb found in the Pacific islands), have been investigated by US researchers. The results of these studies into the effects of kava in adults with daily stress and anxiety were presented at the Second World Congress on Stress [Melbourne, Australia; October 1998].
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|